JAMES B BREITMEYER
CIK 1244823 · Chief Executive Officer · last filed 2026-05-01
JAMES B BREITMEYER is a Chief Executive Officer who has filed 65 SEC Form 4 insider transactions across 4 companies since 2007. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
65
-$1.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Chief Executive Officer | 443,767 | $0.53 | $233.7K | $86.0K | 22 | 2024-02-15 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 5 | 2022-06-23 |
| ZOGENIX, INC. (ZGNX) Delisted | Director | 6,250 | $26.68 | $166.8K | -$500.0K | 10 | 2021-05-28 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | EVP, CMO | 10,000 | — | — | -$1.04M | 26 | 2012-03-16 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-01 | — | Grant (A) | +78,800 | $0 | |
| 2024-02-15 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-05 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Tax (F) | −55,440 | -$27.5K | EDGAR |
| 2023-10-04 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Mixed | — | $0 | EDGAR |
| 2023-07-05 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Tax (F) | −51,999 | -$18.7K | EDGAR |
| 2023-04-17 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Buy (P) | +150,000 | $43.9K | EDGAR |
| 2023-02-24 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Tax (F) | −29,118 | -$29.7K | EDGAR |
| 2022-08-01 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | +204,375 | $0 | EDGAR |
| 2022-06-23 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |